TITLE

Public perception A significant challenge in the battle against HPV

AUTHOR(S)
Rosberger, Zeev; Perez, Samara; King, Leonora; Franco, Eduardo L.
PUB. DATE
May 2013
SOURCE
Oncology Exchange;May2013, Vol. 12 Issue 2, p16
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
HPV accounts for 5.2% of the worldwide cancer burden, including all cervical cancers, 50% of penile cancers and 88% of anal cancers. Two vaccines have recently been developed and licensed to target specific oncogenic and non-oncogenic types of HPV. In 2006, the Canadian government supported a vaccination program for girls aged 9 to 13 and female vaccination rates in this population in Canada now range from 50% in Alberta to 86% in Quebec. There are compelling reasons to include boys in the vaccination campaign as well. Two provmces have recently stated their intention to do so. Perceptions of individuals and parents are important in vaccine acceptance. Understanding how their decisions are made will help design measures to improve vaccine uptake.
ACCESSION #
88033148

 

Related Articles

  • Cervarix PI updated.  // Australian Journal of Pharmacy;Aug2011, Vol. 92 Issue 1095, p48 

    The article offers information on the product information (PI) of the Cervarix human papillomavirus (HPV) vaccine, which was shown as highly effective against cervical pre-cancerous lesions caused by HPV types 16 and 18.

  • Bye bye pap tests?  // Herizons;Fall98, Vol. 12 Issue 3, p11 

    Reports that drugs company Merck and Co. is developing a vaccine to prevent cervical cancer. Human papilloma virus (HPV) as cause of the cancer.

  • One dose of HPV vaccine protected against cervical cancer for 4 years.  // Infectious Disease News;Dec2013, Vol. 26 Issue 12, p31 

    The article reports that a single dose of the human papillomavirus (HPV) 16/18 vaccine provided a durable antibody response against cervical cancer for 4 years, according to a study by author Mahboobeh Safaeian and colleagues, published in a 2013 issue of the "Cancer Prevention Research" journal.

  • Healthcare Report: Educating the public - Case study.  // Campaign Asia-Pacific;Oct2010, p94 

    The article offers information on the campaign related to the launch of cervical cancer vaccination, Cervarix by GlaxoSmithKline (GSK) in Japan. It mentions that the aim of the campaign was to motivate women to receive vaccination. It mentions that the strategies of the campaign includes,...

  • Editorial: HPV-associated cancers, socio-economic disparity, and vaccination. Alsbeih, Ghazi // Frontiers in Oncology;Oct2015, p1 

    An introduction is presented which discusses topics discussed in the issue including HPV-related cancers, association between HPV, cervical cancer, and socio-economic status, and vaccinations for cervical cancers.

  • Association Study between Cervical Lesions and Single or Multiple Vaccine-Target and Non-Vaccine Target Human Papillomavirus (HPV) Types in Women from Northeastern Brazil. Chagas, Bárbara Simas; Comar, Manola; Gurgel, Ana Pavla Almeida Diniz; Paiva, Sérgio; Seraceni, Silva; de Freitas, Antonio Carlos; Crovella, Sergio // PLoS ONE;7/15/2015, Vol. 10 Issue 7, p1 

    We performed an association between high-grade squamous intraepithelial lesions (HSIL), low-grade squamous intraepithelial lesions (LSIL) and single or multiple vaccine-target as well as non-vaccine target Human papillomavirus (HPV) types. Using bead-based HPV genotyping, 594 gynecological...

  • Cervical Cancer and Human Papilloma Virus Vaccine : Awareness and Acceptability among Nursing Staff in a Tertiary Health Care Hospital. Verma, Kalpana; Surwade Vidya M; Aggarwal, Rajani // Indian Journal of Public Health Research & Development;Jul-Sep2015, Vol. 6 Issue 3, p297 

    Background: Cervical Cancer is the second-most common cancer in women worldwide; which can be prevented by HPV vaccine. Objectives: (1) To assess the awareness about cancer cervix and associated risk factors. (2) To assess the awareness regarding HPV vaccine (3) To study the acceptability of the...

  • Skin Vaccination against Cervical Cancer Associated Human Papillomavirus with a Novel Micro-Projection Array in a Mouse Model. Corbett, Holly J.; Fernando, Germain J. P.; Xianfeng Chen; Frazer, Ian H.; Kendall, Mark A. F. // PLoS ONE;2010, Vol. 5 Issue 10, p1 

    Background: Better delivery systems are needed for routinely used vaccines, to improve vaccine uptake. Many vaccines contain alum or alum based adjuvants. Here we investigate a novel dry-coated densely-packed micro-projection array skin patch (Nanopatchâ„¢) as an alternate delivery system to...

  • HPV vax cost effective in Thailand….  // PharmacoEconomics & Outcomes News;2/18/2012, Issue 647, p3 

    The article discusses research on the cost effectiveness of human papillomavirus (HPV) vaccine in Thailand. It references a study by W. Termrungruanglert and colleagues, published in "Value in Health." The study found that HPV vaccination reduced mortality rate by 54.8 percent and lifetime rates...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics